Search results
May 13, 2022 · Malignant hyperthermia is a severe reaction to certain drugs used for anesthesia. This severe reaction typically includes a dangerously high body temperature, rigid muscles or spasms, a rapid heart rate, and other symptoms.
Apr 25, 2022 · Malignant hyperthermia is a serious and life-threatening reaction to certain anesthesia medications. The good news is that it’s treatable and even preventable if you know you’re at risk for the condition.
Aug 17, 2023 · Malignant hyperthermia (MH) is a hereditary disorder of skeletal muscle that classically presents as a hypermetabolic response to halogenated anesthetic gasses and/or the depolarizing muscle relaxant succinylcholine.
May 13, 2022 · This rare genetic disorder triggers a severe reaction to certain anesthesia drugs, causing rigid muscles, high fever, fast heart rate and rapid breathing.
Malignant hyperthermia (MH) is a type of severe reaction that occurs in response to particular medications used during general anesthesia, among those who are susceptible. Symptoms include muscle rigidity, fever, and a fast heart rate. Complications can include muscle breakdown and high blood potassium.
Mar 26, 2024 · Malignant hyperthermia (MH) manifests clinically as a hypermetabolic crisis when an MH-susceptible (MHS) individual is exposed to a volatile anesthetic (eg, halothane, isoflurane, sevoflurane, desflurane) or succinylcholine .
Malignant hyperthermia is a rare, life-threatening rise in body temperature that occurs in susceptible people who are given certain muscle-relaxing drugs plus an anesthetic gas for surgery. Malignant hyperthermia can occur when the anesthesia is given or during or soon after surgery.
Malignant hyperthermia is a severe reaction to particular anesthetic drugs that are often used during surgery and other invasive procedures. Explore symptoms, inheritance, genetics of this condition.
Jan 6, 2022 · Malignant hyperthermia is a potentially lethal syndrome usually triggered by inhalation anaesthetics or succinylcholine (suxamethonium). The underlying genetic susceptibility is most often due to a range of autosomal-dominant mutations in RYR1.
Malignant hyperthermia develops in genetically susceptible patients who have been exposed (usually more than once) simultaneously to a depolarizing muscle relaxant and a potent, volatile inhalational general anesthetic.
